CHIPS Act Funding And Gate-Model Roadmap Could Be A Game Changer For D-Wave Quantum (QBTS)

• D-Wave Quantum Inc. recently outlined an expanded gate-model roadmap targeting up to 100 logical qubits by 2032 and highlighted its dual-platform approach, alongside securing a letter of intent for up to US$100 million in CHIPS and Science Act funding from the U.S. Department of Commerce.
• A recent reshuffle of board leadership and committee roles, coupled with fresh U.S. government support, underlines how governance and public-sector backing are becoming central to D-Wave’s quantum commercialization efforts.
• Next, we’ll examine how the CHIPS Act funding commitment reshapes D-Wave Quantum’s investment narrative and its long-term commercialization outlook.

AI is about to change healthcare. These 39 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

D-Wave Quantum Investment Narrative Recap

To own D-Wave Quantum, you need to believe that its superconducting, dual-platform approach can turn early quantum adoption and government partnerships into a scalable, recurring QCaaS and systems business. The near term catalyst is whether strong bookings, including recent large contracts, start converting into revenue fast enough to narrow losses. The new board reshuffle and CHIPS Act funding letter do not materially change that execution risk, but they do sharpen attention on governance and public funding reliance.

The most relevant update here is the letter of intent for up to US$100 million in CHIPS and Science Act funding, which comes alongside D-Wave’s expanded gate-model roadmap toward 100 logical qubits by 2032. This potential capital injection, tied to issuing shares to the U.S. Department of Commerce, could support hardware and QCaaS capacity just as investors are watching whether lumpy system sales and early-stage QCaaS usage can transition into steadier, higher margin growth.

Yet behind the excitement around government backing, investors should still be aware of how exposed D-Wave remains to a handful of large, lumpy deals...

Read the full narrative on D-Wave Quantum (it's free!)

D-Wave Quantum's narrative projects $122.5 million revenue and $15.2 million earnings by 2028. This requires 71.8% yearly revenue growth and a $414.0 million earnings increase from $-398.8 million today.

Uncover how D-Wave Quantum's forecasts yield a $38.54 fair value, a 47% upside to its current price.

Exploring Other Perspectives

Some of the most optimistic analysts were assuming revenue could reach about US$180.2 million with US$22.2 million in earnings by 2029, which is far more bullish than consensus and leans heavily on rapid QCaaS scale up and multi year system deals; after the latest U.S. funding news, you might find your own view sits somewhere very different along that spectrum.

Explore 34 other fair value estimates on D-Wave Quantum - why the stock might be worth over 5x more than the current price!

Form Your Own Verdict

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your D-Wave Quantum research is our analysis highlighting 1 key reward and 3 important warning signs that could impact your investment decision.
• Our free D-Wave Quantum research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate D-Wave Quantum's overall financial health at a glance.

Searching For A Fresh Perspective?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• Find 47 companies with promising cash flow potential yet trading below their fair value.
• Capitalize on the AI infrastructure supercycle with our selection of the 48 best 'picks and shovels' of the AI gold rush converting record-breaking demand into massive cash flow.
• Rare earth metals are the new gold rush. Find out which 32 stocks are leading the charge.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com